[{"uuid": "d787a381-7da8-3dfb-9b05-780a880274ae", "title": "Medexus and Ontario's Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada", "publisher": "Newsfile", "link": "https://finance.yahoo.com/news/medexus-ontarios-provincial-health-services-120000545.html", "providerPublishTime": 1738670400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CRX6pToj8xxCgZvsl7r2jg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/a647a713d3d5f69f93ab888f076ce971", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3y7TXoGfIwWu9b1qQKGTGw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/newsfile_64/a647a713d3d5f69f93ab888f076ce971", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["MEDXF"]}, {"uuid": "8669b6bc-5f79-39b6-a288-12b7d714e9a5", "title": "Neopharma Technologies and Impairment Science Strengthen Partnership to Revolutionize Drug and Impairment Testing", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/neopharma-technologies-impairment-science-strengthen-085900989.html", "providerPublishTime": 1738659540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qz5qn1dSemtzb6y6WwL2cw--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/4668691d9ba0bf92f3dae9711897e23b", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/I92ruufC_WJQlU7yhbrL9Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/4668691d9ba0bf92f3dae9711897e23b", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "fde86dd8-aafd-3f34-b8c8-2b323b3535db", "title": "Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema", "publisher": "Reuters", "link": "https://finance.yahoo.com/news/investors-seek-answers-novo-nordisks-061007042.html", "providerPublishTime": 1738649407, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/wT4W0oYU7l.TKowiCxAP8w--~B/aD01MjU7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/c7954da1c3a9f8499e1984e1cb085f22", "width": 800, "height": 525, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/devTXWnxDGTDozgv.3h1mA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/reuters-finance.com/c7954da1c3a9f8499e1984e1cb085f22", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NVO", "LLY"]}, {"uuid": "f1e173df-9549-386b-8ef7-33e17d8be3a1", "title": "Frenchman on death row in Indonesia leaves jail ahead of transfer home", "publisher": "AFP", "link": "https://finance.yahoo.com/m/f1e173df-9549-386b-8ef7-33e17d8be3a1/frenchman-on-death-row-in.html", "providerPublishTime": 1738670571, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/VoTgj_Ah74rDUgba5gJt7w--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/37cd496b6bda45d5e665af92b097a3e8", "width": 768, "height": 512, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/T_MSemwC6HZYtMv_iERO0w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/afp.com/37cd496b6bda45d5e665af92b097a3e8", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "344864d0-ca83-3a5e-b33c-ee327d75a7b0", "title": "Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?", "publisher": "Motley Fool", "link": "https://finance.yahoo.com/m/344864d0-ca83-3a5e-b33c-ee327d75a7b0/vertex-pharma-just-scored-a.html", "providerPublishTime": 1738671000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QO9rqa.hvWMoKxfutVKSnw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/38048d87fcdd3a5512efda9e154e7931", "width": 1400, "height": 933, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NqzQuMUtHMfxsUFhEEqBwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/38048d87fcdd3a5512efda9e154e7931", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["VRTX"]}, {"uuid": "e3978c2b-2afa-3577-8ebb-bc08daefa073", "title": "Pfizer beats profit estimates on heart disease drug, COVID vaccine sales", "publisher": "Reuters", "link": "https://finance.yahoo.com/news/pfizer-beats-fourth-quarter-profit-115327840.html", "providerPublishTime": 1738670007, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/DyjdbmtrhEHSM_nYCjaenw--~B/aD00NzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/fe1d68298de0b8a2b8d3e6e0665f182d", "width": 800, "height": 473, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Eh0BrYBW7tca955Ni.tb2g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/reuters-finance.com/fe1d68298de0b8a2b8d3e6e0665f182d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PFE"]}, {"uuid": "15747c78-8e35-3d42-835c-752fe89e1cdd", "title": "CN Bio Launches PhysioMimix DILI Assay Kit: Human 24, for Enhanced Preclinical Toxicology Testing", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/cn-bio-launches-physiomimix-dili-092900693.html", "providerPublishTime": 1738661340, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Hi.fJRxh6Zq.qCqRTo_upA--~B/aD0yNTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c5569e953e9c44c7d8df1b4b0c66d8f3", "width": 480, "height": 251, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/YZiH7RZOfEFA.DsDGQG2BA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/c5569e953e9c44c7d8df1b4b0c66d8f3", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "86680548-294a-32b4-8c86-42e2dd554e6b", "title": "Vanda and AnaptysBio link for generalised pustular psoriasis therapy", "publisher": "Pharmaceutical Technology", "link": "https://finance.yahoo.com/m/86680548-294a-32b4-8c86-42e2dd554e6b/vanda-and-anaptysbio-link-for.html", "providerPublishTime": 1738669079, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gJt7Ob0yq33NcLbQIhvRGg--~B/aD05MDA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/60c77b0a51558da306829c3278fc6786", "width": 1440, "height": 900, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/iLzvQM1WXh1UqdLtqOP2LQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/60c77b0a51558da306829c3278fc6786", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["VNDA", "ANAB"]}, {"uuid": "00274315-7c46-36e0-bd97-075c9e0d8425", "title": "Nurix Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/nurix-therapeutics-participate-oppenheimer-35th-120000469.html", "providerPublishTime": 1738670400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/eAnNqpmgC4JUYgzPGVHRCA--~B/aD01OTt3PTEyNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/2bac359058f8ba3c51bd304c2eb375c0", "width": 124, "height": 59, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/51hl1dZ4gPf3sTPkaBjw6g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2bac359058f8ba3c51bd304c2eb375c0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NRIX"]}, {"uuid": "14c7a50b-d2b9-3d0e-8cf1-6244f3c1d3f6", "title": "A Preview of Clinical Trials Set to Launch and Conclude in 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/preview-clinical-trials-set-launch-095100507.html", "providerPublishTime": 1738662660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "width": 480, "height": 58, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/KPtVInxraKsLNBMRw1U5aw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "64f3402a-edcb-3c5c-8806-834845666bb1", "title": "CT drug counselor gets prison for collecting about $1M phony Medicaid billings", "publisher": "Hartford Courant", "link": "https://finance.yahoo.com/m/64f3402a-edcb-3c5c-8806-834845666bb1/ct-drug-counselor-gets-prison.html", "providerPublishTime": 1738616880, "type": "STORY"}, {"uuid": "e27e55c4-25cf-34b2-98bf-d8a5d8f06390", "title": "Merck pauses Gardasil shipments to China, hitting its 2025 outlook", "publisher": "Reuters", "link": "https://finance.yahoo.com/news/merck-pauses-gardasil-shipments-china-113234269.html", "providerPublishTime": 1738668754, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Hh0H1FhTStwEu5lNZwYk_A--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/ed53dee46e6c2d7632a66827e9bd5bae", "width": 800, "height": 533, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/02kGMxr6WDlEY7esquj0sA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/reuters-finance.com/ed53dee46e6c2d7632a66827e9bd5bae", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "1779c951-7ab1-3fea-a675-d6c278bee843", "title": "Ecuadoran drug gangs turn to death saint for protection", "publisher": "AFP", "link": "https://finance.yahoo.com/m/1779c951-7ab1-3fea-a675-d6c278bee843/ecuadoran-drug-gangs-turn-to.html", "providerPublishTime": 1738632357, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/GcNT94fMeLiiTdcMQ74XaA--~B/aD01MTE7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/aa960ab0afe8e9ad8ad61c7c551bb105", "width": 768, "height": 511, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oAyPOkDXKR_7.iiF4WlYBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/afp.com/aa960ab0afe8e9ad8ad61c7c551bb105", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "a816265b-2b32-3b14-9817-027b840dc08d", "title": "Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/alys-pharmaceuticals-receives-ind-clearance-083000900.html", "providerPublishTime": 1738657800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5Ge5McdcVP41j4rMEWSVAA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a34dd732b88b5186f1dc99cc21834255", "width": 16, "height": 16, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/UEX180OWF_qO1Gduc5dRhQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/a34dd732b88b5186f1dc99cc21834255", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "dbf99977-debc-3db0-8dd0-e8da5dc9bbe0", "title": "Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results; Initiates Quarterly Dividend and Increases Total Share Repurchase Capacity to ~$4.5 Billion", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/regeneron-reports-fourth-quarter-full-113000067.html", "providerPublishTime": 1738668600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBn5GKQBxPWKQ64h5BTqqw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 800, "height": 126, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Z.v1_LzEKhIPoy9U5NlmXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN"]}, {"uuid": "4040f44b-06a3-3944-b0c2-51c6c6119975", "title": "Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects", "publisher": "Newsfile", "link": "https://finance.yahoo.com/news/appointment-dr-bryan-jones-advisor-120000423.html", "providerPublishTime": 1738670400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gjib7FGpkShDRJEch9zdfA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/ff713e0d58d82205d350a322d5bf882f", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/C_PrOQKiDHIr7EuuWT.dNw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/newsfile_64/ff713e0d58d82205d350a322d5bf882f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["PRVCF"]}, {"uuid": "d80328dd-aeb0-3899-87d6-63425eba3e3f", "title": "FDA Greenlights Studies of Pig Kidney Transplants in Humans", "publisher": "Bloomberg", "link": "https://finance.yahoo.com/news/fda-greenlights-studies-pig-kidney-221902996.html", "providerPublishTime": 1738621142, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/3jioTgA8MjM1C7FQvoqUIQ--~B/aD03NDc7dz0xMTIwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/9b30fae2755177e569f259653788ced5", "width": 1120, "height": 747, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fuH9DM8czWCYWp7GPWpFnw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/9b30fae2755177e569f259653788ced5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["UTHR"]}, {"uuid": "bf77af79-cd90-325d-85cb-e02dd6f3d85c", "title": "RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/redhill-announces-initiation-phase-2-120000083.html", "providerPublishTime": 1738670400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/YJPZyTSOAz79b9jtDhF1MA--~B/aD0yMjY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/4fefa5aba37b5a4ecc13dada34b1c97d", "width": 400, "height": 226, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0KurZ6M2ORAsc5VHYRhAyw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/4fefa5aba37b5a4ecc13dada34b1c97d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["RDHL"]}, {"uuid": "fb6a8f60-0dbf-342b-b7a4-096e9924c55e", "title": "Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/tonix-pharmaceuticals-promotes-siobhan-fogarty-120000854.html", "providerPublishTime": 1738670400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/x8OenoHLlZtilFbGLk.hYQ--~B/aD0zODA7dz04MTU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2260880378e4d1a1a54ac9ee6eda14bf", "width": 815, "height": 380, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/muHsCf1rvj7P2tB5cWTaQg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2260880378e4d1a1a54ac9ee6eda14bf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["TNXP"]}, {"uuid": "a273dd96-9314-390c-9f38-a073de2c410e", "title": "Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/5-big-drug-stocks-surpass-162000365.html", "providerPublishTime": 1738599600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gw9hjYsV9oVXUgeEGEfgLQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/ecnM_GSyzlN5rf_uf5pFog--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/f91db6bb14dedc17d5edb20f29c41da3", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["LLY", "PFE"]}]